To include your compound in the COVID-19 Resource Center, submit it here.

Grifols, Talecris deal

Grifols plans to acquire fellow plasma protein company Talecris in a cash and stock deal that the companies said values

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE